Logo image of ALTRI.PA

TRILOGIQ (ALTRI.PA) Stock Fundamental Analysis

Europe - EPA:ALTRI - FR0010397901 - Common Stock

5.3 EUR
0 (0%)
Last: 11/12/2025, 7:00:00 PM
Fundamental Rating

5

ALTRI gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 109 industry peers in the Machinery industry. While ALTRI has a great health rating, its profitability is only average at the moment. ALTRI has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year ALTRI was profitable.
In the past year ALTRI had a positive cash flow from operations.
In multiple years ALTRI reported negative net income over the last 5 years.
ALTRI had a positive operating cash flow in 4 of the past 5 years.
ALTRI.PA Yearly Net Income VS EBIT VS OCF VS FCFALTRI.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2022 2023 2024 2025 0 5M -5M

1.2 Ratios

ALTRI's Return On Assets of 2.53% is in line compared to the rest of the industry. ALTRI outperforms 47.71% of its industry peers.
Looking at the Return On Equity, with a value of 2.80%, ALTRI is doing worse than 63.30% of the companies in the same industry.
With a Return On Invested Capital value of 0.57%, ALTRI is not doing good in the industry: 77.06% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA 2.53%
ROE 2.8%
ROIC 0.57%
ROA(3y)1.54%
ROA(5y)N/A
ROE(3y)1.72%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ALTRI.PA Yearly ROA, ROE, ROICALTRI.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2022 2023 2024 2025 0 5 -5 -10 -15 -20

1.3 Margins

The Profit Margin of ALTRI (4.57%) is better than 60.55% of its industry peers.
In the last couple of years the Profit Margin of ALTRI has grown nicely.
ALTRI has a worse Operating Margin (1.16%) than 77.06% of its industry peers.
In the last couple of years the Operating Margin of ALTRI has grown nicely.
ALTRI has a Gross Margin of 63.63%. This is amongst the best in the industry. ALTRI outperforms 89.91% of its industry peers.
ALTRI's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 1.16%
PM (TTM) 4.57%
GM 63.63%
OM growth 3Y17.04%
OM growth 5YN/A
PM growth 3Y25.71%
PM growth 5YN/A
GM growth 3Y1.99%
GM growth 5Y12.3%
ALTRI.PA Yearly Profit, Operating, Gross MarginsALTRI.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2022 2023 2024 2025 0 20 -20 40 60

9

2. Health

2.1 Basic Checks

ALTRI has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, ALTRI has about the same amount of shares outstanding.
The number of shares outstanding for ALTRI remains at a similar level compared to 5 years ago.
ALTRI has a better debt/assets ratio than last year.
ALTRI.PA Yearly Shares OutstandingALTRI.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2022 2023 2024 2025 1M 2M 3M
ALTRI.PA Yearly Total Debt VS Total AssetsALTRI.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2022 2023 2024 2025 20M 40M 60M

2.2 Solvency

An Altman-Z score of 5.57 indicates that ALTRI is not in any danger for bankruptcy at the moment.
ALTRI has a better Altman-Z score (5.57) than 93.58% of its industry peers.
The Debt to FCF ratio of ALTRI is 0.01, which is an excellent value as it means it would take ALTRI, only 0.01 years of fcf income to pay off all of its debts.
With an excellent Debt to FCF ratio value of 0.01, ALTRI belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
ALTRI has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
ALTRI's Debt to Equity ratio of 0.00 is amongst the best of the industry. ALTRI outperforms 97.25% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.01
Altman-Z 5.57
ROIC/WACC0.07
WACC8.15%
ALTRI.PA Yearly LT Debt VS Equity VS FCFALTRI.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2022 2023 2024 2025 0 20M 40M

2.3 Liquidity

ALTRI has a Current Ratio of 9.71. This indicates that ALTRI is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of ALTRI (9.71) is better than 99.08% of its industry peers.
ALTRI has a Quick Ratio of 8.58. This indicates that ALTRI is financially healthy and has no problem in meeting its short term obligations.
ALTRI has a better Quick ratio (8.58) than 100.00% of its industry peers.
Industry RankSector Rank
Current Ratio 9.71
Quick Ratio 8.58
ALTRI.PA Yearly Current Assets VS Current LiabilitesALTRI.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2022 2023 2024 2025 10M 20M 30M 40M

1

3. Growth

3.1 Past

The earnings per share for ALTRI have decreased strongly by -32.65% in the last year.
ALTRI shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 29.14% yearly.
ALTRI shows a decrease in Revenue. In the last year, the revenue decreased by -3.60%.
Measured over the past years, ALTRI shows a decrease in Revenue. The Revenue has been decreasing by -0.29% on average per year.
EPS 1Y (TTM)-32.65%
EPS 3Y29.14%
EPS 5YN/A
EPS Q2Q%-122.02%
Revenue 1Y (TTM)-3.6%
Revenue growth 3Y2.81%
Revenue growth 5Y-0.29%
Sales Q2Q%-14%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-2.78%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year5.12%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ALTRI.PA Yearly Revenue VS EstimatesALTRI.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M
ALTRI.PA Yearly EPS VS EstimatesALTRI.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 0.5 -0.5 1 -1 1.5

4

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 18.28, ALTRI is valued on the expensive side.
Compared to the rest of the industry, the Price/Earnings ratio of ALTRI indicates a somewhat cheap valuation: ALTRI is cheaper than 66.06% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 25.91, ALTRI is valued a bit cheaper.
Based on the Price/Forward Earnings ratio of 14.70, the valuation of ALTRI can be described as correct.
The rest of the industry has a similar Price/Forward Earnings ratio as ALTRI.
When comparing the Price/Forward Earnings ratio of ALTRI to the average of the S&P500 Index (34.57), we can say ALTRI is valued rather cheaply.
Industry RankSector Rank
PE 18.28
Fwd PE 14.7
ALTRI.PA Price Earnings VS Forward Price EarningsALTRI.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Price/Free Cash Flow ratio of ALTRI indicates a rather cheap valuation: ALTRI is cheaper than 81.65% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 9
EV/EBITDA -23.34
ALTRI.PA Per share dataALTRI.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for ALTRI!.
Industry RankSector Rank
Dividend Yield N/A

TRILOGIQ

EPA:ALTRI (11/12/2025, 7:00:00 PM)

5.3

0 (0%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)07-24 2024-07-24/amc
Earnings (Next)N/A N/A
Inst Owners1.72%
Inst Owner ChangeN/A
Ins Owners76.77%
Ins Owner ChangeN/A
Market Cap19.82M
Revenue(TTM)23.20M
Net Income(TTM)1.06M
Analysts86.67
Price Target6.12 (15.47%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 18.28
Fwd PE 14.7
P/S 0.85
P/FCF 9
P/OCF 8.21
P/B 0.52
P/tB 0.52
EV/EBITDA -23.34
EPS(TTM)0.29
EY5.47%
EPS(NY)0.36
Fwd EY6.8%
FCF(TTM)0.59
FCFY11.11%
OCF(TTM)0.65
OCFY12.18%
SpS6.2
BVpS10.14
TBVpS10.13
PEG (NY)N/A
PEG (5Y)N/A
Graham Number8.13
Profitability
Industry RankSector Rank
ROA 2.53%
ROE 2.8%
ROCE 0.7%
ROIC 0.57%
ROICexc 1.67%
ROICexgc 1.67%
OM 1.16%
PM (TTM) 4.57%
GM 63.63%
FCFM 9.49%
ROA(3y)1.54%
ROA(5y)N/A
ROE(3y)1.72%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y31.78%
ROICexgc growth 5YN/A
ROICexc growth 3Y31.69%
ROICexc growth 5YN/A
OM growth 3Y17.04%
OM growth 5YN/A
PM growth 3Y25.71%
PM growth 5YN/A
GM growth 3Y1.99%
GM growth 5Y12.3%
F-Score6
Asset Turnover0.55
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.01
Debt/EBITDA 0.02
Cap/Depr 24.77%
Cap/Sales 0.91%
Interest Coverage 250
Cash Conversion 214.48%
Profit Quality 207.83%
Current Ratio 9.71
Quick Ratio 8.58
Altman-Z 5.57
F-Score6
WACC8.15%
ROIC/WACC0.07
Cap/Depr(3y)38.04%
Cap/Depr(5y)N/A
Cap/Sales(3y)1.5%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-32.65%
EPS 3Y29.14%
EPS 5YN/A
EPS Q2Q%-122.02%
EPS Next Y-2.78%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-3.6%
Revenue growth 3Y2.81%
Revenue growth 5Y-0.29%
Sales Q2Q%-14%
Revenue Next Year5.12%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-68.86%
EBIT growth 3Y20.32%
EBIT growth 5YN/A
EBIT Next Year187.5%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-5.85%
FCF growth 3YN/A
FCF growth 5Y-4.81%
OCF growth 1Y-14.72%
OCF growth 3YN/A
OCF growth 5Y-3.83%

TRILOGIQ / ALTRI.PA FAQ

What is the ChartMill fundamental rating of TRILOGIQ (ALTRI.PA) stock?

ChartMill assigns a fundamental rating of 5 / 10 to ALTRI.PA.


What is the valuation status of TRILOGIQ (ALTRI.PA) stock?

ChartMill assigns a valuation rating of 4 / 10 to TRILOGIQ (ALTRI.PA). This can be considered as Fairly Valued.


Can you provide the profitability details for TRILOGIQ?

TRILOGIQ (ALTRI.PA) has a profitability rating of 4 / 10.


What are the PE and PB ratios of TRILOGIQ (ALTRI.PA) stock?

The Price/Earnings (PE) ratio for TRILOGIQ (ALTRI.PA) is 18.28 and the Price/Book (PB) ratio is 0.52.


Can you provide the financial health for ALTRI stock?

The financial health rating of TRILOGIQ (ALTRI.PA) is 9 / 10.